Abstract
Cardiovascular outcomes of SGLT-2 inhibitors’ subtypes in type 2 diabetes; an updated systematic review and meta-analysis of randomized controlled trials
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have